Analysis of differentially expressed mRNAs among healthy controls and NASH patients using publicly available data (GSE89632) [45] revealed that hepatic expression of ORMDL3, but not ORMDL1 or ORMDL2, were significantly upregulated in male but not female NASH samples compared to healthy controls. This evidence concerns the gene ORMDL1 and metabolic dysfunction-associated steatohepatitis.